載入...
A Randomized Clinical Trial of Metformin to treat Autosomal Dominant Polycystic Kidney Disease
BACKGROUND: Metformin inhibits cyclic AMP generation and activates AMP-activated protein kinase (AMPK), which inhibits the cystic fibrosis transmembrane conductance regulator and Mammalian Target of Rapamycin pathways. Together these effects may reduce cyst growth in autosomal dominant polycystic ki...
Na minha lista:
| 發表在: | Am J Nephrol |
|---|---|
| Main Authors: | , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6010317/ https://ncbi.nlm.nih.gov/pubmed/29779024 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000488807 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|